首页> The British journal of cancer> Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer

Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer

导出原文传递

翻译打印收藏纠错

第一作者： Quenel-Tueux, Nathalie

作者： Quenel-Tueux, Nathalie ^[1] ; Debled, Marc ^[2] ; Rudewicz, Justine ^[3] ; MacGrogan, Gaetan ^[4] ; Pulido, Marina ^[5] ; Mauriac, Louis ^[6] ; Dalenc, Florence ^[7] ; Bachelot, Thomas ; Lortal, Barbara ; Breton-Callu, Christelle ; Madranges, Nicolas ; de lara, Christine Tunon ; Fournier, Marion ; Bonnefoi, Herve ; Soueidan, Hayssam ; Nikolski, Macha ; Gros, Audrey ; Daly, Catherine ; Wood, Henry ; Rabbitts, Pamela ; Iggo, Richard

作者单位： Inst Bergonie, Ctr Comprehens Canc, F-33000 Bordeaux, France ^[1] Univ Bordeaux, Bordeaux Bioinformat Ctr, F-33076 Bordeaux, France ^[2] Univ Leeds, Leeds Inst Canc & Pathol, Leeds LS9 7TF, W Yorkshire, England ^[3] Univ Bordeaux, F-33608 Pessac, France ^[4] INSERM, Clin Invest Ctr, CIC1401, Epidemiol Unit, F-33076 Bordeaux, France ^[5] CLCC Lyon, F-69008 Lyon, France ^[6] Inst Claudius Regaud, IUCT Oncopole Toulouse, F-31059 Toulouse, France ^[7]

关键词 anastrozole endocrine treatment fulvestrant hormone-receptor-positive cancer large operable or locally advanced breast cancer neo-adjuvant

发布时间 2015-09-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交